Dashboard
Manage Tickers

ILMN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

1000-invested-in-this-stock-20-years-ago-would-be-worth-38000-today
$1000 Invested In This Stock 20 Years Ago ...
09/11/2024 19:30:18

european-court-rules-in-favor-of-illumina-in-fight-against-probe-into-grail-deal-asks-not-to-pay-478m-fine
European Court Rules In Favor Of Illumina ...
09/03/2024 13:48:59

Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of...

illumina-hails-ecj-ruling-eliminates-432m-fine-over-grail-acquisition
Illumina Hails ECJ Ruling, Eliminates €432...
09/03/2024 08:05:43

Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, welcomes the European Court of Ju...

peering-into-illuminas-recent-short-interest
Peering Into Illumina's Recent Short Interest
09/02/2024 19:00:22

heres-how-much-1000-invested-in-illumina-20-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Illumina...
08/28/2024 20:30:33

argus-research-upgrades-illumina-to-buy-announces-150-price-target
Argus Research Upgrades Illumina to Buy, A...
08/28/2024 13:31:51

Argus Research analyst Jasper Hellweg upgrades Illumina (NASDAQ:ILMN) from Hold to Buy and announces $150 price target.

fda-approves-illumina-cancer-biomarker-test-with-two-companion-diagnostics-to-rapidly-match-patients-to-targeted-therapies
FDA Approves Illumina Cancer Biomarker Tes...
08/27/2024 13:19:03

TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-ca...

sp-500-nasdaq-100-extend-8-session-winning-streak-as-wall-street-jitters-go-poof-mondays-key-stock-movers
S&P 500, Nasdaq 100 Extend 8-Session Winni...
08/19/2024 20:54:37

Core News & Articles
This HP Analyst Is No Longer Bullish; Here...
08/19/2024 13:36:38

this-cisco-analyst-turns-bullish-here-are-top-5-upgrades-for-friday
This Cisco Analyst Turns Bullish; Here Are...
08/16/2024 12:42:52

alibaba-to-rally-around-11-here-are-10-top-analyst-forecasts-for-friday
Alibaba To Rally Around 11%? Here Are 10 T...
08/16/2024 11:51:24

daiwa-capital-upgrades-illumina-to-buy-raises-price-target-to-154
Daiwa Capital Upgrades Illumina to Buy, Ra...
08/16/2024 09:30:06

Daiwa Capital analyst Narumi Nakagiri upgrades Illumina (NASDAQ:ILMN) from Neutral to Buy and raises the price target from $...

scotiabank-maintains-sector-outperform-on-illumina-lowers-price-target-to-164
Scotiabank Maintains Sector Outperform on ...
08/15/2024 21:04:08

Scotiabank analyst Sung Ji Nam maintains Illumina (NASDAQ:ILMN) with a Sector Outperform and lowers the price target from $1...

1000-invested-in-this-stock-20-years-ago-would-be-worth-47000-today
$1000 Invested In This Stock 20 Years Ago ...
08/14/2024 20:01:11

td-cowen-upgrades-illumina-to-buy-raises-price-target-to-144
TD Cowen Upgrades Illumina to Buy, Raises ...
08/14/2024 17:09:17

TD Cowen analyst Dan Brennan upgrades Illumina (NASDAQ:ILMN) from Hold to Buy and raises the price target from $126 to $144.

rbc-capital-reiterates-outperform-on-illumina-maintains-242-price-target
RBC Capital Reiterates Outperform on Illum...
08/14/2024 15:43:39

RBC Capital analyst Conor McNamara reiterates Illumina (NASDAQ:ILMN) with a Outperform and maintains $242 price target.

this-starbucks-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday
This Starbucks Analyst Turns Bullish; Here...
08/14/2024 13:01:26

barclays-upgrades-illumina-to-equal-weight-announces-125-price-target
Barclays Upgrades Illumina to Equal-Weight...
08/14/2024 11:40:43

Barclays analyst Luke Sergott upgrades Illumina (NASDAQ:ILMN) from Underweight to Equal-Weight and announces $125 price target.

illumina-says-co--broad-institute-of-mit-and-harvard-announce-research-partnership-to-advance-single-cell-sequencing-expects-its-strategy-to-enable-company-to-accelerate-its-revenue-growth-to-high-single-digits-by-2027
Illumina Says Co & Broad Institute Of MIT ...
08/13/2024 15:04:57

- Investor Presentation

illumina-sees-at-least-10-total-eps-growth-over-next-3-years-unveils-strategy-aimed-at-8-9-sales-growth-by-2027
Illumina Sees At Least 10% Total EPS Growt...
08/13/2024 15:00:26

-- Company poised to accelerate revenue growth into high single digits over next three years, enabled by core genomics portfoli...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION